Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Randomized Study Evaluating the in Vivo Efficacies of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under Five Years of Age in Western Kenya

NCT05060198 is registered in ClinicalTrials.gov with Kenya Medical Research Institute as lead sponsor.

NCT NCT05060198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Randomized Study Evaluating the in Vivo Efficacies of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under Five Years of Age in Western Kenya
Lead sponsor
Kenya Medical Research Institute
Phase
Not applicable
Overall status
Completed
Start date
June 17, 2016
Completion date
December 31, 2020
Enrollment
340 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malaria,falciparum